GlaxoSmithKline PLC Director/PDMR Shareholding (6036F)
15 Julio 2019 - 12:16PM
UK Regulatory
TIDMGSK
RNS Number : 6036F
GlaxoSmithKline PLC
15 July 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Ms E Walmsley
=== ========================= ============================================
b) Position/status Chief Executive Officer
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 1482.518
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Mr R G Connor
=== ========================= ============================================
b) Position/status President, Global Vaccines
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP16.2695 667.499
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Ms D Conrad
=== ========================= ============================================
b) Position/status SVP, Human Resources
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 7.244
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Mr J Ford
=== ========================= ============================================
b) Position/status SVP & General Counsel
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 0.000026
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Mr J Ford
=== ========================= ===============================================
b) Position/status SVP & General Counsel
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 11
July 2019.
=== ========================= ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$ 40.6287 0.001
----------
=== ========================= ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-07-12
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=======================================================================
a) Name Mr N Hirons
=== ========================= ============================================
b) Position/status SVP, Global Ethics & Compliance
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 411.435
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================
a) Name Mr N Hirons
=== ========================= ===============================================
b) Position/status SVP, Global Ethics & Compliance
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 11
July 2019
=== ========================= ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$ 40.6287 18.219
----------
=== ========================= ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-07-12
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them ('PCA')
===========================================================================
a) Name Mr D Jackson
=== ========================= ================================================
b) Position/status PCA of Mrs S Jackson (SVP, Global Communications
and CEO Office)
=== ========================= ================================================
c) Initial notification/ Initial notification
amendment
=== ========================= ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ================================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP16.2695 58.941
----------
=== ========================= ================================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ================================================
e) Date of the transaction 2019-07-12
=== ========================= ================================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ================================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Mrs S Jackson
=== ========================= ============================================
b) Position/status SVP, Global Communications and CEO Office
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 89.852
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================
a) Name Mr B McNamara
=== ========================= ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 11
July 2019
=== ========================= ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$ 40.6287 729.935
----------
=== ========================= ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ===============================================
e) Date of the transaction 2019-07-12
=== ========================= ===============================================
f) Place of the transaction New York Stock Exchange (XNYS)
=== ========================= ===============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Mr D Redfern
=== ========================= ============================================
b) Position/status Chief Strategy Officer
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 2454.384
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them
('PCA')
=======================================================================
a) Name Mr R Simard
=== ========================= ============================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 471.834
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Ms K Thomson
=== ========================= ============================================
b) Position/status PCA of Mr P C Thomson (President, Global
Affairs)
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 123.040
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
1. Details of PDMR/person closely associated with them ('PCA')
=======================================================================
a) Name Mr P C Thomson
=== ========================= ============================================
b) Position/status President, Global Affairs
=== ========================= ============================================
c) Initial notification/ Initial notification
amendment
=== ========================= ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ============================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 11 July 2019.
=== ========================= ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP 16.2695 564.406
----------
=== ========================= ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ============================================
e) Date of the transaction 2019-07-12
=== ========================= ============================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDELFFKDFFBBF
(END) Dow Jones Newswires
July 15, 2019 13:16 ET (17:16 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
